Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FATE Fate Therapeutics Inc

交易中 07-22 13:09:39 EDT

4.38

+0.11

+2.46%

最高4.47	最低4.17	成交量42.10万
今开4.33	昨收4.27	日振幅7.14%
总市值4.98亿	流通市值3.96亿	总股本1.14亿
成交额181.56万	换手率0.47%	流通股本9,049万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics Inc","latestPrice":4.375,"timestamp":1721668172000,"preClose":4.27,"halted":0,"volume":421009,"delay":0,"floatShares":90487217,"shares":113831969,"eps":-1.918686,"marketStatus":"交易中","marketStatusCode":2,"change":0.105,"latestTime":"07-22 13:09:39 EDT","open":4.33,"high":4.47,"low":4.165,"amount":1815632.2145606,"amplitude":0.071429,"askPrice":4.38,"askSize":807,"bidPrice":4.37,"bidSize":208,"shortable":3,"etf":0,"ttmEps":-1.918686,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1380600000000,"adjPreClose":4.27,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":4.35,"preClose":4.27,"latestTime":"16:17 EDT","volume":20638,"amount":88132.13,"timestamp":1721420249200},"volumeRatio":0.218797,"impliedVol":2.654,"impliedVolPercentile":0.9163},"requestUrl":"/m/hq/s/FATE/wiki","defaultTab":"wiki","newsList":[{"id":"2452845318","title":"Fate Therapeutics, Inc.盘中异动 下午盘快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452845318","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452845318?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:38","pubTimestamp":1721327926,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时38分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌5.16%。截至发稿，该股报4.23美元/股，成交量164.584万股，换手率1.45%，振幅7.62%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3233.02%、2595.84%、1301.88%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023846af9301e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023846af9301e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2452520001","title":"Fate Therapeutics, Inc.盘中异动 早盘快速下挫5.03%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452520001","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452520001?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:32","pubTimestamp":1721223153,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时32分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌5.03%。截至发稿，该股报4.32美元/股，成交量3.4555万股，换手率0.03%，振幅1.54%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Aditxt, Inc.、Longeveron Inc.、Aptevo Therapeutics Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为670.85%、484.10%、104.74%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Aditxt, Inc.、Aptevo Therapeutics Inc.，振幅分别为18.75%、13.13%、10.87%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172132339681da6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172132339681da6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2451599716","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.14%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451599716","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451599716?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:35","pubTimestamp":1721136910,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时35分，Fate Therapeutics, Inc.股票出现波动，股价急速拉升5.14%。截至发稿，该股报4.09美元/股，成交量4.7358万股，换手率0.04%，振幅4.11%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Scisparc Ltd.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1345.39%、529.59%、80.25%，振幅较大的相关个股有Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Seres Therapeutics, Inc.，振幅分别为21.50%、21.25%、21.01%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213510af929922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213510af929922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2451672543","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451672543","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451672543?lang=zh_cn&edition=full","pubTime":"2024-07-16 03:22","pubTimestamp":1721071338,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日03时22分，Fate Therapeutics, Inc.股票出现波动，股价快速上涨5.12%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3435.12%、183.88%、140.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Scinai Immunotherapeutics Ltd，振幅分别为150.36%、110.42%、91.37%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716032219aef9c7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716032219aef9c7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FATE"],"gpt_icon":0},{"id":"2450395235","title":"Fate Therapeutics, Inc.盘中异动 早盘急速拉升5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450395235","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450395235?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:42","pubTimestamp":1720791779,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时42分，Fate Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为932.12%、82.82%、32.85%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Kazia Therapeutics Limited，振幅分别为66.24%、20.00%、16.53%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214259941f6a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214259941f6a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2450368680","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.13%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368680","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450368680?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:34","pubTimestamp":1720704875,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时34分，Fate Therapeutics, Inc.股票出现波动，股价快速上涨5.13%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为264.93%、191.85%、177.00%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.，振幅分别为31.43%、22.94%、15.15%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213436af91dd61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213436af91dd61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2448167563","title":"Fate Therapeutics, Inc.盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448167563","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448167563?lang=zh_cn&edition=full","pubTime":"2024-07-03 01:29","pubTimestamp":1719941390,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日01时29分，Fate Therapeutics, Inc.股票出现异动，股价急速跳水5.21%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Neurosense Therapeutics Ltd.涨幅较大，Geovax Labs, Inc.、Mustang Bio, Inc.、Gri Bio, Inc.较为活跃，换手率分别为64.64%、61.18%、50.94%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为72.83%、45.22%、39.50%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070301295196818de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070301295196818de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FATE"],"gpt_icon":0},{"id":"2446391954","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.11%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446391954","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446391954?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:08","pubTimestamp":1719410925,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时08分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌5.11%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为439.11%、99.27%、87.32%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为107.88%、51.85%、35.63%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220845af8f58a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220845af8f58a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2445070368","title":"Fate Therapeutics, Inc.盘中异动 急速上涨5.05%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445070368","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445070368?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:14","pubTimestamp":1719238488,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时14分，Fate Therapeutics, Inc.股票出现异动，股价大幅上涨5.05%。截至发稿，该股报3.95美元/股，成交量28.1192万股，换手率0.25%，振幅4.92%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.58%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624221449af8eed2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624221449af8eed2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2444243691","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444243691","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444243691?lang=zh_cn&edition=full","pubTime":"2024-06-18 22:05","pubTimestamp":1718719533,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日22时05分，Fate Therapeutics, Inc.股票出现异动，股价快速下跌5.60%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：派杰投资分析师Edward Tenthoff上调$Fate Therapeutics $至买入评级，并将目标价从4美元上调至6美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618220534941ef3c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618220534941ef3c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2444167369","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167369","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444167369?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631066,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分，Fate Therapeutics, Inc.股票出现异动，股价急速上涨5.54%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：派杰投资分析师Edward Tenthoff上调$Fate Therapeutics $至买入评级，并将目标价从4美元上调至6美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721310795b9dd60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721310795b9dd60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FATE"],"gpt_icon":0},{"id":"2444116388","title":"BUZZ-因疾病治疗取得进展，Piper Sandler 将 Fate 的评级上调至 \"增持\"。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116388","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116388?lang=zh_cn&edition=full","pubTime":"2024-06-17 19:16","pubTimestamp":1718622981,"startTime":"0","endTime":"0","summary":"    6月17日 - ** 生物制药公司Fate Therapeutics   股价盘前上涨10.25%，至3.98美元，成交量低迷。** Piper Sandler将该公司的推荐评级从 \"中性 \"上调至 \"增持\"，并将目标价从4美元上调至6美元，理由是该公司在从癌症治疗向自身免疫疾病治疗转型方面取得了进展。** 经纪公司称：\"Fate Therapeutics 公司正专注于开发治疗自身免疫性疾病的 iPSC 衍生细胞疗法，其 FT819 I 期研究的早期结果令人鼓舞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","FATE"],"gpt_icon":0},{"id":"2442549275","title":"Fate Therapeutics, Inc.盘中异动 大幅拉升6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442549275","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442549275?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199083,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Fate Therapeutics, Inc.股票出现波动，股价急速上涨6.43%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Avidity Biosciences, Inc.、Passage Bio, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.27%、18.90%、3.57%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2442473238","title":"Fate Therapeutics, Inc.盘中异动 早盘快速下挫5.30%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442473238","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442473238?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:49","pubTimestamp":1718027385,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时49分，Fate Therapeutics, Inc.股票出现异动，股价大幅跳水5.30%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Surrozen Inc C/Wts 01/08/2031 、Dermata Therapeutics Inc C/Wts 涨幅较大，Cns Pharmaceuticals, Inc.、Hoth Therapeutics, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为37.90%、36.70%、33.44%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Renovaro Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为131.76%、50.39%、35.94%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214946941ed6a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214946941ed6a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FATE"],"gpt_icon":0},{"id":"2440921789","title":"Fate Therapeutics Inc——5月30日爱德华·杜拉克三世发布了辞去首席财务官职务的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2440921789","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440921789?lang=zh_cn&edition=full","pubTime":"2024-06-01 05:45","pubTimestamp":1717191946,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Inc——5月30日爱德华·杜拉克三世发布了辞去首席财务官职务的通知","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601054548958189e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601054548958189e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2440921786","title":"Fate Therapeutics Inc-董事会打算任命 J. Scott Wolchko 接替杜拉克担任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2440921786","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440921786?lang=zh_cn&edition=full","pubTime":"2024-06-01 05:45","pubTimestamp":1717191942,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Inc-董事会打算任命 J. Scott Wolchko 接替杜拉克担任首席财务官","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406010545479f0cb5a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406010545479f0cb5a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2439509827","title":"Fate Therapeutics, Inc.盘中异动 下午盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439509827","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439509827?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:55","pubTimestamp":1717005342,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时55分，Fate Therapeutics, Inc.股票出现波动，股价快速跳水5.01%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Onconetix, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Mustang Bio, Inc.涨幅较大，Mustang Bio, Inc.、Onconetix, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为533.42%、348.15%、112.38%，振幅较大的相关个股有Onconetix, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为228.43%、117.00%、50.40%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530015542aef25a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530015542aef25a69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2436946699","title":"Fate Therapeutics, Inc.2024财年第一财季实现净利润-48.00百万美元，同比减少154.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436946699","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436946699?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:26","pubTimestamp":1715963214,"startTime":"0","endTime":"0","summary":"3月31日，Fate Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-48.00百万美元，同比减少154.24%；其中营业收入为1.93百万美元，同比减少96.73%，每股基本收益为-0.47美元。机构评级：截至2024年3月31日，当前有16家机构对Fate Therapeutics, Inc.目标价做出预测，其中目标均价为6.81美元，其中最低目标价为4.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180026578b131de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180026578b131de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ"],"gpt_icon":0},{"id":"2435519403","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.06%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519403","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519403?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693570,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分，Fate Therapeutics, Inc.股票出现波动，股价急速上涨5.06%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：加拿大投资银行集团：维持Fate Therapeutics评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132507a59d890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132507a59d890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2435782693","title":"Fate Therapeutics, Inc.盘中异动 早盘大幅上涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435782693","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435782693?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607078,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时31分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升5.39%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：加拿大投资银行集团：维持Fate Therapeutics评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213118861eccba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213118861eccba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fatetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1828},{"period":"1month","weight":0.2522},{"period":"3month","weight":-0.1086},{"period":"6month","weight":-0.0574},{"period":"1year","weight":-0.0404},{"period":"ytd","weight":0.1417}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fate Therapeutics, Inc.于2007年4月27日在特拉华州合并，是一家临床分期生物制药公司，致力于成体干细胞治疗调节器的探索与开发，治疗罕见疾病，包括一些恶性血液病、溶酶体贮积症和肌肉营养不良。Fate使用的一些新方法采用已有的治疗模式，包括小分子和治疗性蛋白，并瞄准良好的生物机制，以增强成体干细胞的疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.058546},{"month":2,"riseRate":0.636364,"avgChangeRate":0.08272},{"month":3,"riseRate":0.545455,"avgChangeRate":0.019657},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.055265},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.016902},{"month":6,"riseRate":0.545455,"avgChangeRate":0.010259},{"month":7,"riseRate":0.454545,"avgChangeRate":0.027006},{"month":8,"riseRate":0.4,"avgChangeRate":0.007076},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015658},{"month":10,"riseRate":0.2,"avgChangeRate":-0.084781},{"month":11,"riseRate":0.545455,"avgChangeRate":0.090798},{"month":12,"riseRate":0.636364,"avgChangeRate":0.109378}],"exchange":"NASDAQ","name":"Fate Therapeutics Inc","nameEN":"Fate Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fate Therapeutics Inc,FATE,Fate Therapeutics Inc股票,Fate Therapeutics Inc股票老虎,Fate Therapeutics Inc股票老虎国际,Fate Therapeutics Inc行情,Fate Therapeutics Inc股票行情,Fate Therapeutics Inc股价,Fate Therapeutics Inc股市,Fate Therapeutics Inc股票价格,Fate Therapeutics Inc股票交易,Fate Therapeutics Inc股票购买,Fate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}